BCR-signaling-induced cell death demonstrates dependency on multiple BH3-only proteins in a murine model of B-cell lymphoma

Cell Death and Differentiation

Volumn 23, Issue 2, 2016, Pages 303-312

  Carter, M J ^a   Cox, K L ^a   Blakemore, S J ^a   Bogdanov, Y D ^a   Happo, L ^b   Scott, C L ^b   Strasser, A ^b   Packham, G K ^a   Cragg, M S ^a  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; ANTIBODY; ANTINEOPLASTIC AGENT; B LYMPHOCYTE RECEPTOR; B LYMPHOCYTE RECEPTOR ANTIBODY; BIM PROTEIN; FOSTAMATINIB; IMMUNOGLOBULIN M; IMMUNOGLOBULIN M ANTIBODY; N (2,3 DIHYDROXYPROPOXY) 3,4 DIFLUORO 2 (2 FLUORO 4 IODOANILINO)BENZAMIDE; PEPTIDES AND PROTEINS; PROTEIN BCL 2; PROTEIN BIK; PROTEIN KINASE SYK; PROTEIN NOXA; UNCLASSIFIED DRUG; APOPTOSIS REGULATORY PROTEIN; BCL2L11 PROTEIN, MOUSE; BCR PROTEIN, MOUSE; BIK PROTEIN, MOUSE; BREAKPOINT CLUSTER REGION PROTEIN; MEMBRANE PROTEIN; MITOCHONDRIAL PROTEIN; ONCOPROTEIN; PMAIP1 PROTEIN, MOUSE; SIGNAL TRANSDUCING ADAPTOR PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; B CELL LYMPHOMA; B-CELL LYMPHOMA CELL LINE; CELL DEATH; CONTROLLED STUDY; DRUG MECHANISM; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; UPREGULATION; ANIMAL; CANCER TRANSPLANTATION; GENETICS; KNOCKOUT MOUSE; METABOLISM; NONOBESE DIABETIC MOUSE; PATHOLOGY; SCID MOUSE; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; BCL-2-LIKE PROTEIN 11; CELL LINE, TUMOR; LYMPHOMA, B-CELL; MEMBRANE PROTEINS; MICE, INBRED NOD; MICE, KNOCKOUT; MICE, SCID; MITOCHONDRIAL PROTEINS; NEOPLASM TRANSPLANTATION; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; PROTO-ONCOGENE PROTEINS C-BCR; SIGNAL TRANSDUCTION;

EID: 84954377886     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/cdd.2015.97     Document Type: Article

References (70)

1. Carsetti R, Rosado MM, Wardemann H. Peripheral development of B cells in mouse and man. Immunol Rev 2004; 197: 179-191.
2. Lam KP, Kuhn R, Rajewsky K. In vivo ablation of surface immunoglobulin on mature B cells by inducible gene targeting results in rapid cell death. Cell 1997; 90: 1073-1083.
3. Srinivasan L, Sasaki Y, Calado DP, Zhang B, Paik JH, DePinho RA et al. PI3 kinase signals BCR-dependent mature B cell survival. Cell 2009; 139: 573-586.
4. Nemazee DA, Burki K. Clonal deletion of Lymphocyte-B in a transgenic mouse bearing anti-MHC Class-I antibody genes. Nature 1989; 337: 562-566.
5. Goodnow CC, Crosbie J, Adelstein S, Lavoie TB, Smith-Gill SJ, Brink RA et al. Altered Immunoglobulin expression and functional silencing of self-reactive B-lymphocytes in transgenic mice. Nature 1988; 334: 676-682.
6. Hartley SB, Crosbie J, Brink R, Kantor AB, Basten A, Goodnow CC. Elimination from peripheral lymphoid-tissues of self-reactive B-lymphocytes recognizing membrane-bound antigens. Nature 1991; 353: 765-769.
7. Hardy RR, Hayakawa K. B cell development pathways. Annu Rev Immunol 2001; 19: 595-621.
8. Eldering E, Mackus WJM, Derks IAM, Evers LM, Beuling E, Teeling P et al. Apoptosis via the B cell antigen receptor requires Bax translocation and involves mitochondrial depolarization, cytochrome C release, and caspase-9 activation. Eur J Immunol 2004; 34: 1950-1960.
9. Berard R, Mondiere P, Casamayor-Palleja M, Hennino A, Bella C, Defrance T. Mitochondria connects the antigen receptor to effector caspases during B cell receptor-induced apoptosis in normal human B cells. J Immunol 1999; 163: 4655-4662.
10. Enders A, Bouillet P, Puthalakath H, Xu YK, Tarlinton DM, Strasser A. Loss of the proapoptotic BH3-only Bcl-2 family member Bim inhibits BCR stimulation-induced apoptosis and deletion of autoreactive B cells. J Exp Med 2003; 198: 1119-1126.
11. Vuist WMJ, Levy R, Maloney DG. Lymphoma regression induced by monoclonal antiidiotypic antibodies correlates with their ability to induce signal-transduction and is not prevented by tumor expression of high levels of Bcl-2 protein. Blood 1994; 83: 899-906.
12. Advani RH, Buggy JJ, Sharman JP, Smith SM, Boyd TE, Grant B et al. Bruton tyrosine kinase inhibitor ibrutinib (PCI-32765) has significant activity in patients with relapsed/refractory B-cell malignancies. J Clin Oncol 2013; 31: 88-94.
13. Czabotar PE, Lessene G, Strasser A, Adams JM. Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy. Nat Rev Mol Cell Biol 2014; 15: 49-63.
14. Zou H, Li YC, Liu HS, Wang XD. An APAF-1 center dot cytochrome c multimeric complex is a functional apoptosome that activates procaspase-9. J Biol Chem 1999; 274: 11549-11556.
15. Zong WX, Lindsten T, Ross AJ, MacGregor GR, Thompson CB. BH3-only proteins that bind pro-survival Bcl-2 family members fail to induce apoptosis in the absence of Bax and Bak. Genes Dev 2001; 15: 1481-1486.
16. Wei MC, Zong WX, Cheng EH, Lindsten T, Panoutsakopoulou V, Ross AJ et al. Proapoptotic BAX and BAK: A requisite gateway to mitochondrial dysfunction and death. Science 2001; 292: 727-730.
17. Antonsson B, Montessuit S, Lauper S, Eskes R, Martinou JC. Bax oligomerization is required for channel-forming activity in liposomes and to trigger cytochrome c release from mitochondria. Biochem J 2000; 345: 271-278.
18. Willis SN, Fletcher JI, Kaufmann T, van Delft MF, Chen L, Czabotar PE et al. Apoptosis initiated when BH3 ligands engage multiple Bcl-2 homologs, not Bax or Bak. Science 2007; 315: 856-859.
19. Cheng E, Wei MC, Weiler S, Flavell RA, Mak TW, Lindsten T et al. BCL-2, BCL-X-L sequester BH3 domain-only molecules preventing BAX- and BAK-mediated mitochondrial apoptosis. Mol Cell 2001; 8: 705-711.
20. Strasser A. The role of BH3-only proteins in the immune system. Nat Rev Immunol 2005; 5: 189-200.
21. Afshar-Sterle S, Zotos D, Bernard NJ, Scherger AK, Rödling L, Alsop AE et al. Fas ligandmediated immune surveillance by T cells is essential for the control of spontaneous B cell lymphomas. Nat Med 2014; 20: 283-290.
22. Bouillet P, Metcalf D, Huang DC, Tarlinton DM, Kay TW, Köntgen F et al. Proapoptotic Bcl-2 relative bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity. Science 1999; 286: 1735-1738.
23. Ogilvy S, Metcalf D, Print CG, Bath ML, Harris AW, Adams JM. Constitutive Bcl-2 expression throughout the hematopoietic compartment affects multiple lineages and enhances progenitor cell survival. Proc Natl Acad Sci USA 1999; 96: 14943-14948.
24. Erlacher M, Labi V, Manzl C, Böck G, Tzankov A, Häcker G et al. Puma cooperates with Bim, the rate-limiting BH3-only protein in cell death during lymphocyte development, in apoptosis induction. J Exp Med 2006; 203: 2939-2951.
25. Labi V, Erlacher M, Kiessling S, Manzl C, Frenzel A, O'Reilly L et al. Loss of the BH3-only protein Bmf impairs B cell homeostasis and accelerates gamma irradiation-induced thymic lymphoma development. J Exp Med 2008; 205: 641-655.
26. Wensveen FM, Derks IA, van Gisbergen KP, de Bruin AM, Meijers JC, Yigittop H et al. BH3-only protein Noxa regulates apoptosis in activated B cells and controls high-affinity antibody formation. Blood 119: 1440-1449.
27. Wensveen FM, van Gisbergen KPJM, Derks IA, Gerlach C, Schumacher TN, van Lier RA et al. Apoptosis threshold set by Noxa and Mcl-1 after T cell activation regulates competitive selection of high-affinity clones. Immunity 2010; 32: 754-765.
28. Huebner A, Cavanagh-Kyros J, Rincon M, Flavell RA, Davis RJ. Functional cooperation of the proapoptotic Bcl2 family proteins Bmf and Bim in vivo. Mol Cell Biol 2010; 30: 98-105.
29. Clybouw C, Fischer S, Auffredou MT, Hugues P, Alexia C, Bouillet P et al. Regulation of memory B-cell survival by the BH3-only protein Puma. Blood 118: 4120-4128.
30. Gray DH, Kupresanin F, Berzins SP, Herold MJ, O'Reilly LA, Bouillet P et al. The BH3-only proteins Bim and Puma cooperate to impose deletional tolerance of organ-specific antigens. Immunity 2012; 37: 451-462.
31. Kroesen BJ, Pettus B, Luberto C, Busman M, Sietsma H, de Leij L et al. Induction of apoptosis through B-cell receptor cross-linking occurs via de novo generated C16-ceramide and involves mitochondria. J Biol Chem 2001; 276: 13606-13614.
32. Mouhamad S, Besnault L, Auffredou MT, Leprince C, Bourgeade MF, Leca G et al. B cell receptor-mediated apoptosis of human lymphocytes is associated with a new regulatory pathway of Bim isoform expression. J Immunol 2004; 172: 2084-2091.
33. Takada E, Hata K, Mizuguchi J. Requirement for JNK-dependent upregulation of BimL in anti-IgM-induced apoptosis in murine B lymphoma cell lines WEHI-231 and CH31. Exp Cell Res 2006; 312: 3728-3738.
34. Beers SA, French RR, Chan HT, Lim SH, Jarrett TC, Vidal RM et al. Antigenic modulation limits the efficacy of anti-CD20 antibodies: implications for antibody selection. Blood 2010; 115: 5191-5201.
35. Schuster C, Berger A, Hoelzl MA, Putz EM, Frenzel A, Simma O et al. The cooperating mutation or "second hit" determines the immunologic visibility toward MYC-induced murine lymphomas. Blood 2011; 118: 4635-4645.
36. Oreilly LA, Huang DC, Strasser A. The cell death inhibitor Bcl-2 and its homologues influence control of cell cycle entry. EMBO J 1996; 15: 6979-6990.
37. Rong Y-P, Bultynck G, Aromolaran AS, Zhong F, Parys JB, De Smedt H et al. The BH4 domain of Bcl-2 inhibits ER calcium release and apoptosis by binding the regulatory and coupling domain of the IP3 receptor. Proc Natl Acad Sci USA 2009; 106: 14397-14402.
38. Cande C, Cohen I, Daugas E, Ravagnan L, Larochette N, Zamzami N et al. Apoptosisinducing factor (AIF): a novel caspase-independent death effector released from mitochondria. Biochimie 2002; 84: 215-222.
39. Saleh A, Srinivasula SM, Acharya S, Fishel R, Alnemri ES. Cytochrome c and dATPmediated oligomerization of Apaf-1 is a prerequisite for procaspase-9 activation. J Biol Chem 1999; 274: 17941-17945.
40. Li LY, Luo L, Wang XD. Endonuclease G is an apoptotic DNase when released from mitochondria. Nature 2001; 412: 95-99.
41. Askew DS, Ashmun RA, Simmons BC, Cleveland JL. Constitutive c-Myc expression in an IL-3-dependent myeloid cell-line suppresses cell-cycle arrest and accelerates apoptosis. Oncogene 1991; 6: 1915-1922.
42. Coultas L, Terzano S, Thomas T, Voss A, Reid K, Stanley EG et al. Hrk/DP5 contributes to the apoptosis of select neuronal populations but is dispensable for haematopoietic cell apoptosis. J Cell Sci 2007; 120: 2044-2052.
43. Happo L, Phipson B, Smyth GK, Strasser A, Scott CL. Neither loss of Bik alone, nor combined loss of Bik and Noxa, accelerate murine lymphoma development or render lymphoma cells resistant to DNA damaging drugs. Cell Death Dis 3: e306.
44. Chen WP, Wang HG, Srinivasula SM, Alnemri ES, Cooper NR. B cell apoptosis triggered by antigen receptor ligation proceeds via a novel caspase-dependent pathway. J Immunol 1999; 163: 2483-2491.
45. Herold MJ, Kuss AW, Kraus C, Berberich I. Mitochondria-dependent caspase-9 activation is necessary for antigen receptor-mediated effector caspase activation and apoptosis in WEHI 231 lymphoma cells. J Immunol 2002; 168: 3902-3909.
46. O'Reilly LA, Ekert P, Harvey N, Marsden V, Cullen L, Vaux DL et al. Caspase-2 is not required for thymocyte or neuronal apoptosis even though cleavage of caspase-2 is dependent on both Apaf-1 and caspase-9. Cell Death Differ 2002; 9: 832-841.
47. Marsden VS, Ekert PG, Van Delft M, Vaux DL, Adams JM, Strasser A. Bcl-2-regulated apoptosis and cytochrome c release can occur independently of both caspase-2 and caspase-9. J Cell Biol 2004; 165: 775-780.
48. Clybouw C, Merino D, Nebl T, Masson F, Robati M, O'Reilly L et al. Alternative splicing of Bim and Erk-mediated Bim(EL) phosphorylation are dispensable for hematopoietic homeostasis in vivo. Cell Death Differ 2012; 19: 1060-1068.
49. Ley R, Ewings KE, Hadfield K, Cook SJ. Regulatory phosphorylation of Bim: sorting out the ERK from the JNK. Cell Death Differ 2005; 12: 1008-1014.
50. Ley R, Balmanno K, Hadfield K, Weston C, Cook SJ. Activation of the ERK1/2 signaling pathway promotes phosphorylation and proteasome-dependent degradation of the BH3-only protein, Bim. J Biol Chem 2003; 278: 18811-18816.
51. Luciano F, Jacquel A, Colosetti P, Herrant M, Cagnol S, Pages G et al. Phosphorylation of Bim-EL by Erk1/2 on serine 69 promotes its degradation via the proteasome pathway and regulates its proapoptotic function. Oncogene 2003; 22: 6785-6793.
52. Hughes R, Gilley J, Kristiansen M, Ham J. The MEK-ERK pathway negatively regulates bim expression through the 3 ' UTR in sympathetic neurons. BMC Neurosci 2011: 12.
53. Romano G, Acunzo M, Garofalo M, Di Leva G, Cascione L, Zanca C et al. MiR-494 is regulated by ERK1/2 and modulates TRAIL-induced apoptosis in non-small-cell lung cancer through BIM down-regulation. Proc Natl Acad Sci USA 2012; 109: 16570-16575.
54. Irish JM, Czerwinski DK, Nolan GP, Levy R. Altered B-cell receptor signaling kinetics distinguish human follicular lymphoma. B cells from tumor-infiltrating nonmalignant B cells. Blood 2006; 108: 3135-3142.
55. Jiang AM, Clark EA. Involvement of Bik, a proapoptotic member of the Bcl-2 family, in surface IgM-mediated B cell apoptosis. J Immunol 2001; 166: 6025-6033.
56. Bretz J, Garcia J, Huang X, Kang L, Zhang Y, Toellner KM et al. Noxa mediates p18(INK4c) cell-cycle control of homeostasis in B cells and plasma cell precursors. Blood 117: 2179-2188.
57. Villunger A, Michalak EM, Coultas L, Müllauer F, Böck G, Ausserlechner MJ et al. p53- and drug-induced apoptotic responses mediated by BH3-only proteins Puma and Noxa. Science 2003; 302: 1036-1038.
58. Oda E, Ohki R, Murasawa H, Nemoto J, Shibue T, Yamashita T et al. Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis. Science 2000; 288: 1053-1058.
59. Kim JY, Ahn HJ, Ryu JH, Suk K, Park JH. BH3-only protein noxa is a mediator of hypoxic cell death induced by hypoxia-inducible factor 1 alpha. J Exp Med 2004; 199: 113-123.
60. Alves NL, Derks IA, Berk E, Spijker R, van Lier RA, Eldering E. The Noxa/Mcl-1 axis regulates susceptibility to apoptosis under glucose limitation in dividing T cells. Immunity 2006; 24: 703-716.
61. Rodriguez R, Matsuda M, Perisic O, Bravo J, Paul A, Jones NP et al. Tyrosine residues in phospholipase C gamma 2 essential for the enzyme function in B-cell signaling. J Biol Chem 2001; 276: 47982-47992.
62. Du H, Wolf J, Schafer B, Moldoveanu T, Chipuk JE, Kuwana T. BH3 domains other than Bim and Bid can directly activate Bax/Bak. J Biol Chem 2011; 286: 491-501.
63. Nijhawan D, Fang M, Traer E, Zhong Q, Gao W, Du F et al. Elimination of Mcl-1 is required for the initiation of apoptosis following ultraviolet irradiation. Genes Dev 2003; 17: 1475-1486.
64. Coultas L, Bouillet P, Loveland KL, Meachem S, Perlman H, Adams JM et al. Concomitant loss of proapoptotic BH3-only bcl-2 antagonists Bik and Bim arrests spermatogenesis. EMBO J 2005; 24: 3963-3973.
65. Coultas L, Bouillet P, Stanley EG, Brodnicki TC, Adams JM, Strasser A. Proapoptotic BH3-only Bcl-2 family member Bik/Blk/Nbk is expressed in hemopoietic and endothelial cells but is redundant for their programmed death. Mol Cell Biol 2004; 24: 1570-1581.
66. Spender LC, O'Brien DI, Simpson D, Dutt D, Gregory CD, Allday MJ et al. TGF-beta induces apoptosis in human B cells by transcriptional regulation of BIK and BCL-X-L. Cell Death Differ 2009; 16: 593-602.
67. Letai A, Bassik MC, Walensky LD, Sorcinelli MD, Weiler S, Korsmeyer SJ. Distinct BH3 domains either sensitize or activate mitochondrial apoptosis, serving as prototype cancer therapeutics. Cancer Cell 2002; 2: 183-192.
68. Adams JM, Harris AW, Pinkert CA, Corcoran LM, Alexander WS, Cory S et al. The c-Myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice. Nature 1985; 318: 533-538.
69. Happo L, Cragg MS, Phipson B, Haga JM, Jansen ES, Herold MJ et al. Maximal killing of lymphoma cells by DNA damage-inducing therapy requires not only the p53 targets Puma and Noxa, but also Bim. Blood 2010; 116: 5256-5267.
70. Michalak EM, Jansen ES, Happo L, Cragg MS, Tai L, Smyth GK et al. Puma and to a lesser extent Noxa are suppressors of Myc-induced lymphomagenesis. Cell Death Differ 2009; 16: 684-696.